Aclaris Therapeutics Prices $50.0 Million Offering of Common Stock and Pre-Funded Warrants
The offering comprises 7.7857 million shares of common stock and 6.5 million pre-funded warrants, for gross proceeds of approximately $50 million.
BTC+1.11%
ETH+1.63%
SOL+0.96%
XRP+2.39%
USDC-0.03%
NOMO+2,770.60%
SUI+1.47%
NEAR+5.31%BTC+1.11%ETH+1.63%SOL+0.96%XRP+2.39%USDC-0.03%NOMO+2,770.60%SUI+1.47%NEAR+5.31%BTC+1.11%ETH+1.63%SOL+0.96%XRP+2.39%USDC-0.03%NOMO+2,770.60%SUI+1.47%NEAR+5.31%BTC+1.11%ETH+1.63%SOL+0.96%XRP+2.39%USDC-0.03%NOMO+2,770.60%SUI+1.47%NEAR+5.31%
